Review of precision cancer medicine: Evolution of the treatment paradigm-Reference-Cited by-同舟云学术

Review of precision cancer medicine: Evolution of the treatment paradigm

Published:2020-06 Issue: Volume:86 Page:102019
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Tsimberidou Apostolia M.,Fountzilas Elena,Nikanjam Mina,Kurzrock Razelle

Funder

NIH

NCI

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference130 articles.

1. Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers;Von Hoff;J Clin Oncol,2010

2. Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative;Tsimberidou;Clin Cancer Res,2012

3. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses;Tsimberidou;Clin Cancer Res,2014

4. Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study. JCO Precis;Tsimberidou;Oncol,20172017

5. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Le Tourneau;Lancet Oncol,2015

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Familial Cancers;International Encyclopedia of Public Health;2025

2. Insights into 5-fluorouracil anti–cancer drug encapsulation within the pristine and palladium-doped carbon, silicon-carbide, and germanium-carbide nanotubes: A DFT investigation for advanced nanomedicine applications;Materials Science in Semiconductor Processing;2024-11

3. Association of COX-inhibitors with cancer patients’ survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis;Frontiers in Oncology;2024-09-13

4. Tumor‐Resident Microbiota‐Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients;Advanced Science;2024-09-13

5. Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment;Ear & Hearing;2024-09-12